Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases
- 10 February 2013
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 21 (7), 1843-1852
- https://doi.org/10.1007/s00520-013-1741-7
Abstract
A common side effect of chemotherapy treatment is diarrhoea. Unfortunately, the underlying mechanisms of chemotherapy-induced diarrhoea (CD) are poorly understood. We aimed to determine if faecal microbes of CD patients were displaced, if faecal calprotectin increased during CD and if there were alterations in circulating matrix metalloproteinases, nuclear factor kappa B (NF-κB), IL-1β and TNF. Twenty-six cancer patients receiving chemotherapy were enrolled and requested to provide stool samples and blood samples at various times during their chemotherapy cycle. Stool samples were analysed using conventional culture techniques and qRT-PCR. ELISA kits determined faecal calprotectin levels, levels of circulating matrix metalloproteinases and circulating NF-κB, IL-1β and TNF. The majority of patients with CD showed decreases in Lactobacillus spp., Bifidobacterium spp., Bacteroides spp. and Enterococcus spp. Increases were observed in Escherichia coli and Staphylococcus spp. Methanogenic archaea were also quantified, with all patients except one showing a decrease. Faecal calprotectin levels were increased in 81.25 % of patients with CD. Circulating MMP-3 and MMP-9 significantly increased following chemotherapy. Circulating levels of NF-κB, IL-1β and TNF were increased following chemotherapy, although this did not reach significance. We demonstrated that CD is associated with marked changes in intestinal microflora, methanogenic archaea, matrix metalloproteinase and serum levels of NF-κB, IL-1β and TNF. These changes may result in diminished bacterial functions within the gut, altering gut function and initiating intestinal damage, resulting in the onset of diarrhoea. More importantly, these changes may provide clinicians with a possible new target for biomarkers of toxicity.Keywords
This publication has 43 references indexed in Scilit:
- Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41Proceedings of the National Academy of Sciences of the United States of America, 2008
- Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysisBMC Microbiology, 2008
- Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen speciesThe EMBO Journal, 2007
- Bacteroides: the Good, the Bad, and the Nitty-GrittyClinical Microbiology Reviews, 2007
- The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugsCancer Treatment Reviews, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Development of Bacteroides 16S rRNA Gene TaqMan-Based Real-Time PCR Assays for Estimation of Total, Human, and Bovine Fecal Pollution in WaterApplied and Environmental Microbiology, 2006
- Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategiesSupportive Care in Cancer, 2006
- Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the ratClinical and Experimental Medicine, 2005
- Competition for hydrogen between sulphate‐reducing bacteria and methanogenic bacteria from the human large intestineJournal of Applied Bacteriology, 1988